AGEN
NASDAQ
$4.97
Agenus Inc (AGEN)
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $30 (+503.62%)
Market Cap
$193M
Profit Margin
52.2%
Forward P/E
2.29
P/E Ratio
3.01
Price Chart
Valuation
Market Cap$193M
P/E3.01
Forward P/E2.29
PEG1.44
P/S1.71
P/B218.61
Profitability
Total Revenue (TTM)$124M
Gross Profit (TTM)$121M
EBITDA$16M
Profit Margin52.2%
Operating Margin44.6%
EPS$1.66
Financial Health
Debt-to-Equity-27.3%
Free Cash Flow Yield-45.35%
Growth & Risk
Revenue 5Y CAGR+7.88%
FCF 5Y CAGR-10.26%
Beta (5Y)1.16
Sharpe Ratio0.18